anti-CD171 ADC(APITBIO/AbTis)

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug Nameanti-CD171 ADC(APITBIO/AbTis)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payload
Mechanisms of Actionanti-Neural cell adhesion molecule L1DNA topoisomerase I inhibitorsTubulin inhibitors
TargetsNeural cell adhesion molecule L1DNA topoisomerase ITubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApitbio IncAbTis Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAbTis Co LtdApitbio Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A